Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if his Department will support the (a) rollout and (b) expansion of testing for (i) hepatitis B, (ii) hepatitis C, (iii) HIV, (iv) other precursor conditions to less survivable cancers and (v) NHS England’s risk-stratified Community Liver Health Check programme.

Testing for hepatitis B, C, and HIV is available through a variety of routes including, primary care, sexual health services and targeted testing to reach groups most at risk of infections. NHS England’s opt-out testing programme operates at several emergency departments and tests all adults blood test for hepatitis B, C, and HIV, unless they opt out. NHS England is exploring whether funding can be identified to allow the programme to continue beyond the current financial year.

The Department supports testing for precursor conditions to less survivable cancers through several programmes. The NHS Cancer Programme works to detect more hepatocellular carcinomas, namely liver cancer, at an early stage. Six-monthly liver ultrasound surveillance for patients with cirrhosis or advanced fibrosis is carried out to identify liver cancers earlier. In 2025/26, community liver health checks will continue to be rolled out across 20 areas to identify patients with cirrhosis or advanced fibrosis.

To speed up diagnosis of cancer, a full roll-out of non-specific symptom pathways has been achieved in England. These introduce a diagnosis route for patients displaying symptoms not aligned to specific cancers. This programme has provided funding to Cancer Alliances in 2023/24 and in 2024/25 to invest in local liver surveillance programmes.